United States · Growth startup

Who invested in Vital Therapies

9 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$228Mraised across 9 rounds since 2007, from 9 sources

$28MSeries C$16MRound$23MSeries D$4.3MVenture$2.5MDebt$86MGrowth$23MVenture$32MGrowth$14MGrowth

Latest round: Growth, $14MMar 2014
Biggest round: $86MGrowth · Nov 2012
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2008200920102011201220132014

$28MSeries C$16MRound$23MSeries D$4.3MVenture$2.5MDebt$86MGrowth$23MVenture$32MGrowth$14MGrowth

First round: Series C, $28M
Biggest round: $86M
Usual gap between rounds: 7 months

The rounds

Mar 2014
Growth$14M
No investor was named in the report.
From a historical funding recordSEC filing: $14M sold, first sale Jan 2014
Jan 2014
Growth$32M
No investor was named in the report.
From a historical funding recordSEC filing: $32M sold, first sale Feb 2013
Jun 2013
Venture$23M
No investor was named in the report.
Reported by sec.govSEC filing: $23M sold, first sale Feb 2013
Nov 2012
Growth$86M
No investor was named in the report.
Reported by sec.govSEC filing: $86M sold, first sale Sept 2012
Jun 2012
Debt$2.5M
No investor was named in the report.
Reported by sec.govSEC filing: $2.5M sold, first sale May 2012
Feb 2012
Venture$4.3M1 new
- DFJ
From a historical funding recordSEC filing: $930K sold, first sale Feb 2012
Jun 2011
Series D$23M
No investor was named in the report.
Reported by sec.govSEC filing: $23M sold, first sale May 2011
Jun 2011
Round$16M
No investor was named in the report.
Reported by sec.govSEC filing: $16M sold, first sale Sept 2009
Oct 2007
Series C$28M4 new
From a historical funding record